NASDAQ:MEDS • US89846A4058
| TTM (2024-6-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -19.33M | -13.72M | -3.91M | -5.32M | -2.54M | |||
| Depreciation Amortization | 825.17K | 834.17K | 10.00K | 10.00K | 10.00K | |||
| Change In Working Capital | 2.32M | 5.66M | 440.00K | 1.08M | -3.60M | |||
| Interest Paid | 493.69K | 733.69K | 340.00K | 30.00K | 30.00K | |||
| Taxes Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other non cash items | 8.73M | 5.15M | 1.93M | 1.66M | 3.91M | |||
| OPERATING CASH FLOW | -7.44M | -2.07M | -1.53M | -2.57M | -2.21M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | N/A | -450.00K | -20.00K | -40.00K | |||
| Other Investing Activity | 29.24M | -275.72K | 20.00K | N/A | N/A | |||
| INVESTING CASH FLOW | 26.88M | -275.72K | -430.00K | -20.00K | -40.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | 250.00K | 0.00 | -230.00K | 0.00 | |||
| Stock Issued/Repurchased | 28.03K | 1.62K | 130.00K | 20.00K | 6.03M | |||
| Other Financing Activity | -46.64K | 1.15M | -170.00K | 0.00 | -730.00K | |||
| FINANCING CASH FLOW | -12.45M | 1.41M | -40.00K | -210.00K | 5.30M | |||
| CHANGE IN CASH | 6.99M | -942.99K | -2.00M | -2.80M | 3.05M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -7.44M | -2.07M | -1.53M | -2.57M | -2.21M | |||
| Capital Expenditure | N/A | N/A | -450.00K | -20.00K | -40.00K | |||
| FREE CASH FLOW | -9.80M | -2.07M | -1.98M | -2.59M | -2.25M | |||
All data in USD